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KAREN H. ROTHENBERG

Gestational Surrogacy and the Health Care Provider*

Medical advances in new reproductive technologies continue to raise complex
legal and ethical issues. In October 1990, a California Superior Court judge
issued his opinion on the first contested case in this country involving gestational surrogacy. 1 Upholding the surrogacy contract as valid and declaring
that the genetic parents had exclusive custody and parental rights, Judge
Richard Parslow observed: "The IVF genie is out of the bottle and you're
not going to be able to put it back." 2
I contend that we must put part of the genie back into the bottle. Gestational
surrogacy is not an acceptable option for the extension of in vitro fertilization (IVF). This is not a reaction to the facts of the California case, but rather
a recognition that the medicalization of surrogacy as a reproductive technology
attempts to legitimize a practice that professionals should not support.
Following a brief discussion of Johnson v. Calvert, the California case, I
will summarize the status of U.S. and international laws and policies on surrogacy, with particular attention on gestational surrogacy. I will also discuss
ethical positions on surrogacy issued by organizations of health care professionals. With this background established, I will outline my position on why
the ethical and legal risks inherent in gestational surrogacy ... require
professionals to reject it as a reproductive alternative.

JOHNSON V. CALVERT

Crispina Calvert, who had had a hysterectomy, worked as a registered nurse
in the same hospital as Anna Johnson, an ex-Marine and licensed vocational
nurse. A mutual friend introduced them, believing that Anna wanted to be a
surrogate. Anna was black and a single parent of a three-year-old girl. She
had had two prior miscarriages and two stillbirths. Crispina was Filipino and
her husband, Mark, was white. The Calverts claimed that they could not afford
to go to a surrogacy agency, but paid $3,500 for the agency's standard contract
and some legal advice. Johnson signed the contract. 3
It is unclear whether Anna was ever screened as an "appropriate"
F.K. Beller and R.F. Weir (eds.), The Beginning of Human Life, 101-113.
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surrogate. Crispina and Anna both began hormonal therapy to mesh their
ovulation cycles. Crispina had a number of eggs removed and fertilized with
Mark's sperm, and three were transferred into Anna. Against the odds, one
embryo implanted. For weeks, Anna received hormonal injections to maximize
her chances of maintaining the pregnancy. She was hospitalized more than
once for complications during the pregnancy. She was also advised to seek
psychiatric help for emotional problems:~
The deal seemed to be working. Anna would receive $10,000 for her
gestational services and for relinquishing the baby, the Calverts would have
a genetic child, and the IVF program would contribute to another expansion
of IVF for women who would otherwise not be able to benefit from such
technology. But Anna, for whatever reason, changed her mind, and the deal
began to fall apart. Seeking to invalidate the contract, she claimed among other
things that she had bonded with the fetus and sought the court's protection
of her future parental rights. Unwilling to recognize the possibility of three
parents and Anna's role as the gestational mother (and probably doubting
her claim that she had, in fact, bonded), the judge declared the contract valid
and granted full and exclusive custody to the Calverts. 5 Anna Johnson filed
an appeal on October 24, 1990. 6

U.S. AND INTERNATIONAL DEVELOPMENTS IN POLICIES ON SURROGACY
Since the Baby M case made headlines a few years ago, policies on surrogacy continue to evolve around the world. 7 In the United States, legislation
has been introduced in Congress and in thirty-nine states, as well as the District
of Columbia, to deal with various aspects of commercial surrogacy. 8 To
date, only thirteen states have passed laws dealing with surrogate parenting
contracts and their legality. Eleven states have either declared commercial
surrogacy illegal and/or made it impossible to enforce a contract as contrary
to public policy. 9 A few of these states specifically include g~stational
surrogacy within their definitional sections. 10 Arkansas allows for ·a birth
certificate to be changed to recognize that the intended mother rather than
the surrogate is the legal mother, but is vague about the parameters of the
legality of surrogacy. 11 New Hampshire's recent statute permits, but with
extensive regulation and pre-approval by the court, both forms of surrogacy. 12
No statute gives more rights to the surrogate with a genetic connection than
to the gestational surrogate. 13
Bioethical task forces in both New Jersey and New York have also recommended that surrogacy not be allowed, particularly in the commercial
setting, and that the surrogate be given the right to keep the child. 14 In fact,
the New Jersey Task Force recommends that it be criminal for professionals
to participate in commercial surrogacy. The prohibition can subject the
professional to a charge of unprofessional conduct and prosecution. 15 Such
participation in surrogacy might include screening of candidates and
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performing artificial insemination and embryo transfer with a gestational
surrogate.
The most recent survey of international laws and policies clearly establishes
that surrogacy contracts, especially if commercial, are illegal, unenforceable,
contrary to public policy and/or void. 16 Furthermore, most laws establish that
the birth mother is deemed the legal mother. 17
Of particular interest, Bulgaria declares that motherhood is determined by
birth, whether or not conception is with another's genetic material. 18 Israeli
regulations establish that a fertilized egg may be implanted only in the intended
mother. 19 In Norway and Sweden, a fertilized egg may only be placed back
into the woman from which the egg was removed. 20 In Spain, surrogacy with
or without money is null and void, but if there is a contract for gestation, it
declares that the mother who gave birth is still the mother. 21 The United
Kingdom bans commercial surrogacy agencies from engaging women to act
as su~TQgate mothers/2 and the German parliament just passed a law banning
both surrogate motherhood and embryo transfer. 23
The Council of Europe has declared that "maternity should be determined
by the fact of giving birth, rather than genetics (origin of the ova), firstly
because of the relationship between the child and the woman giving birth to
him and, secondly, because of the necessity of giving the child a clear legal
situation at birth." 24 Furthermore, absent an exceptional case, surrogate
motherhood should be banned and such contracts should be deemed null and
void. 25 The council cautions that physicians should be prohibited from bringing
together an infertile couple and a surrogate mother. 26
Health-professional organizations both in the United States and abroad have
also taken positions. The American Medical Association in December of
1988 incorporated its earlier report on surrogacy into the official opinions of
its Council on Ethical and Judicial Affairs. Whether genetic or gestational,
the opinion states that surrogacy "does not represent a satisfactory reproductive alternative for people who wish to become parents.'m This past June,
the Ethics Committee of the American Fertility Society also reissued, with
minor changes, its position recommending that surrogacy and gestational surrogacy be continued only as a "clinical experiment". 28 The Committee on Ethics
of the American College of Obstetrics and Gynecology (ACOG) just issued
its revised opinion in "Ethical Issues in Surrogate Motherhood." 29 The committee found that the surrogate who both carries the fetus and delivers the infant
should be the sole source of consent for all questions regarding prenatal care
and delivery, and that she should have a specified time after birth to decide
whether or not to place the child for adoption with the commissioning couple.
The opinion specifically addresses, in part, gestational surrogacy and recognizes that while the genetic link to the couple is important, it deems it "less
weighty than the link between the surrogate mother and the fetus or infant
that is created through gestation and birth.'' 30 Thus, the opinion makes no
ethical distinction between what it describes as "the usual pattern of surrogate parenting and surrogate gestational motherhood.'' 31
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The ACOG committee further states that the physician, when approached,
should assure all disclosure of medical and ethical risk and that the provider
may justifiably decline participating in a surrogacy arrangement. If the
physician does agree to participate, strict ethical guidelines should be followed.
Of particular interest is that the surrogate and the commissioning couple should
be regarded as distinct parties and should be separately represented, both
medically and legally. 32
In August 1990, the Working Party on Human Infertility Services of the
British Medical Association (BMA) adopted extensive ethical guidelines on
surrogacyY These guidelines supersede a 1987 ruling that doctors should
not take part in surrogacy arrangements until the BMA had agreed upon ethical
controls. 34 The BMA guidelines warn physicians that surrogacy arrangements
are unenforceable in law and that neither of the parties can be prevented
from breach. 35 The guidelines provide that surrogacy be a last resort, that
' doctors consider as surrogates only those women who have a partner and
already have one child. Physicians should also warn the commissioning couple,
the surrogate, and her partner of all risks (which the BMA outlines in great
detail), including the possibility that the surrogate may refuse to relinquish
the child and that the commissioning couple may refuse to accept a child
born with any defects. 36 The Working Party makes no ethical or legal distinction
between "partial" (genetic) and "full" (gestational) surrogacy. In fact, they note
that "whatever the genetic origins of a child, and regardless of the wishes of
the participants, the law regards the child as belonging to the mother who delivered it." 37

GESTATIONAL SURROGACY: ETHICAL AND LEGAL PROBLEMS

The American College of Obstetrics and Gynecology and the British Medical
Association both have accepted the political reality that infertility specialists
fear restrictions on their practice. In fact, some IVF programs are part of the
created demand for legalized surrogacy. Surrogacy in this medical context
reduces gestation to a technological tool. This is understandable, considering
the increasing expectation of the couple believing that with enough technology
anyone can have a baby.
At the same time this medicalization reduces the role played by the gestational mother in the creation of life. The surrogate is deemed to be making
a healthy adjustment if she remains unconnected - the most unnatural of
feelings. This is too great a risk for health care professionals to contribute
to reducing women to extensions of a medical process.
Furthermore, as an international matter, gestational surrogacy has the
potential to exploit poor women from Third World countries, perhaps raising
the false hope of immigration to the United States. Rich white couples, in turn,
desperate for a genetic connection, can use poor women to achieve the result.
Health care professionals cannot condone using women in this way.
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I would strongly urge that health professionals resist any support of the
use of a gestational surrogate. Obviously we all want to satisfy the infertile
couple with the option of IVF. But we have to set limits when another woman,
also being treated as a unit by the IVF program, is involved. We are pitting
mothers against each other, and the health care provider is potentially in the
middle of the conflict. The right law, the right contract, and the right counseling will not be able to correct the problems with gestational surrogacy.
I do not make this argument in defense of Anna Johnson, or in reaction
to that case. Although I am surprised that we have not seen more cases to
date, they will come, and the health care provider will be in a no-win position. 38
Let me highlight the specific issues that gestational surrogacy poses for the
health care professional throughout the process.
Screening
PropOnents of surrogacy believe that with enough screening by qualified
professionals, surrogacy can be a success. The recent New Hampshire statute, 39
in fact, provides for professional screening of both the couple and the
surrogate to assure a court in a pre-approval process that the contract will work.
Yet what are we screening for?
For example, how does a psychologist assess whether a gestational
surrogate is a good risk? 40 If she is less willing to want to bond because
there is no genetic connection, will she remain this way throughout the
gestational process? And what if she continues to feel removed, because
there is no genetic connection? Will this influence her prenatal behavior to
make her a bad risk and a noncompliant patient? The data does not exist to
develop the perfect profile of the surrogate and the commissioning couple who
can cope with IVF and embryo transfer. What are the measures of motivation, self-esteem, family support, and experience in coping with childbearing
loss? What relationship will the genetic and the gestational mother have to
each other? What perception does the surrogate have of the father and the future
of a unit relationship? Certainly we do not have experience with genetic parents
dealing with loss to the gestational mother.
We do have some experience that supports the possibility of motivation
to deny or omit feelings and relevant medical information. And there may
be unconscious motivation not to hear or appreciate all the risks when the
motivation is so strong for both the couple and the IVF program to achieve
a pregnancy, and for the surrogate to be successful and to be paid.
In the first medical malpractice case filed that involved the treatment of a
surrogate, Mounce v. Hanson, 41 the surrogate admitted to the physician who
took her medical history that she had had two prior miscarriages and no live
births. She was not screened out. Perhaps more important, she did not state
that she had had a history of heart trouble. She was desperate to serve as a
surrogate, perhaps as a way to deal with her prior losses, and to make some
money. In her eighth month of pregnancy, she died of heart failure following
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a number of warning signals, and the baby died too. The sperm donor never
came forward, but her family has sued Genesearch, the surrogacy program,
the physician who screened her and provided her prenatal care, and the
consulting cardiologist. 42
The Calverts claimed that Anna Johnson also failed to provide important
medical information, in not revealing her two miscarriages and two stillbirths. 43
Clearly, she was not an ideal candidate, either medically or psychologically,
for surrogacy. When money is involved, and when we all want something
bad enough, screening may be of limited use without all the facts. And even
if we think we have all the facts, we have to decide which facts are the ones
that matter.
Thus, in spite of the call for screening to assure that the arrangement has
the Good Housekeeping Seal of Approval, the process is flawed. First of all,
we have no consensus on what we are screening for. Medically, what are the
. -:-standards for an acceptable surrogate? The existence of a uterus and a willing
carrier are not enough. Rather, I would argue that at the present time an
infertile couple is not a candidate for IVF if the woman is not able to be the
birth mother. As noted earlier, Norway, Sweden and Israel require that IVF
be allowed only if the woman is implanted with her own genetic material. 44
Secondly, we do not know what the acceptable psychological profile is
for a low risk couple and surrogate. And finally, professionals are not
qualified to determine what information is meaningful. The ethical and legal,
not to mention medical and psychological, risks are not clear, and by definition, they may never be.
Informed Consent

Assuming that both the couple and the surrogate pass the screening requirements, an elaborate informed consent process is to follow. ACOG, for example,
recommends that the medical and the ethical risks be carefully spelled out
to the couple and the surrogate. 45 The New Hampshire statute also requires
an extensive evaluation, counseling, and an informed consent process. 46 But
are health care providers qualified to do the job? And do they have enough
information to make the process meaningful? How does a gestational surrogate consent knowingly to relinquishment of a future child? She may have
experienced a birth, but is it easier or harder to relinquish if you have no genetic
connection? Is the lack of a genetic connection relevant at all? Obviously,
genetics matter to the couple, who may feel more strongly about losing their
wholly genetic child.
In fact, how does a provider describe the ethical and legal risks? Fewer
than a quarter of the states have laws that either hold surrogacy contracts
unenforceable or heavily regulate them. 47 Under traditional family law, rather
than contract law, the birth mother is the mother. Yet, in Johnson v. Calven
the lower court in California found that genetics is all that matters, and the
gestational mother has no rights. 48
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Clearly, informed consent based on legal risks is risky at best. There are
no guarantees. Nor are there any guarantees with respect to psychological
risk for the couple, the surrogate, or the surrogate's family. Medically, there
are unknown long-term risks associated with fertility drugs, IVF procedures,
risk to the child, and risks to the gestational surrogate from multiple gestation. Obviously, the medical risks are more significant for the gestational
surrogate than for the surrogate who is artificially inseminated and usually
carries just a single fetus to term. Again, it is one thing to risk your own
body. It is quite another to achieve "voluntary" consent to experiment with
another woman's body for the couple's benefit.
Conflict of Interest and the Embryo Transfer
Assu~ing

some form of informed consent is attempted, there still remain
problems with the conflict of interest inherent in an IVF program promoting
embryo transfer with a gestational surrogate. The couple and their surrogate
are treated like a unit with the same interest - the achievement of a
successful pregnancy. The client, however, is not the surrogate but the paying
couple. The surrogate is needed to allow the provider to extend the potential
of IVF use into a "uterine carrier." The surrogate is a means to an end. How
can the physician maintain a confidential relationship with two women who
are both potential mothers of the same baby or babies?
Furthermore, the medical risks are significant for both the genetic and
gestational mother. First, their ovulatory cycles must coincide. Drugs are
necessary to manipulate their cycles. Fertility drugs also may help to stimulate the production of eggs by the genetic mother-to-be so that a number of
eggs can be retrieved. The husband's sperm is then combined with the eggs,
and any resulting embryos are transferred into the gestational surrogate. The
surrogate continues to receive hormonal injections for a number of weeks to
maximize the chances of a successful implantation and pregnancy. The IVF
program has a responsibility for the well-being of all members of this unit.
This is a risky business. Once the IVF process is finished, the IVF program
may think its job is over. A pregnancy (or pregnancies) has been achieved,
yet there is potential for future maternal morbidity and mortality for both
mothers-to-be. It is one thing to assume these risks when the genetic mother
is also to be the host uterus. It is different, however, when there is potential
for conflict within the unit. In fact, all the parties cannot be treated as a unit.
They are individual patients, with individual needs, and the provider must avoid
any appearance of conflict of interest. Yet by definition, IVF and embryo
transfer with a gestational surrogate is a case of potential conflict of interest.
The ACOG committee opinion states that conflict of interest must be avoided
by the use of separate medical providers for infertility and care to the
surrogate. 49
For the process to work, will we tolerate inherent conflict which clearly
favors the interests of the consumers of the IVF technology over the surra-
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gate? Does the IVF provider have, in faCt, a physician-patient relationship with
the surrogate, or does the provider take the surrogate as a mere extension of
the procedure? How much responsibility will the IVF program take for
screening a surrogate? If the surrogate is good enough for the couple, is the
surrogate good enough for the IVR provider? It is the responsibility of the
provider to warn the surrogate of all risks, but is this not in conflict with the
couple's goals and interests?
The ACOG committee opinion provides that the surrogate is the
source of all medical decisions with respect to the pregnancy. 5° For in fact,
once the transfer is complete, all biological connections are made by the
gestational mother-to-be. She is more than a uterine container. 51 She
provides all the nutrients and bodily functions necessary to make this
embryo grow into a fetus and then a baby. Clearly the interest of all is in
her physical and emotional well-being. And any psychological counseling
- ~ecessary during pregnancy must be directed to doing what is best for the
pregnant woman.
Multiple Embryo Transfer
It is common IVF practice to transfer at least three fertilized embryos. Some
IVF programs transfer up to six. 52 Obviously, this practice attempts to maximize
the chances of achieving a pregnancy. However, twins, triplets, and maybe
more are to be expected. A World Health Organization study on IVF found
that with the potential for multiple births, maternal morbidity and mortality,
as well as infant morbidity and mortality, significantly increase. 53 If the genetic
mother chooses to take this risk with her body, it is one thing. But health
care professionals should not impose such risks on the gestational surrogate
whose body is being used for the couple's benefit.
Multiple gestation and its risks raise problems for gestational surrogacy that
were not considered with genetic surrogacy, in which single gestation is the
norm. The risks to all parties, including the liability of the IVF physician,
increase. It is more likely that the gestational surrogate will become a high risk
pregnancy, will require a cesarean section delivery, will have more complications and more monitoring, and will be unable to continue working
throughout the pregnancy. And how do we then compensate fairly for this
additional burden of gestational service and for relinquishing more than one
baby?
Obviously the potential conflict of interest for the IVF provider is raised
again. Just how many embryos should be transferred? On the one hand,
selective termination of the "extra" fetuses might be the answer for the genetic
couple. 54 But what about the surrogate's view? Perhaps she will not want to
abort and will risk carrying three or four to term. Of course, this decision
also raises the risk to her and the fetuses.
Ultimately, if the gestational surrogate is the decisionmaker for medical care,
she and not the genetic couple must decide what is best for her health and
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the health of the fetuses, including selective termination of pregnancy. This
is not to say that the couple and provider will not exert pressure on her.
Prenatal Diagnosis and Genetic Testing

A standard surrogate contract will require the surrogate to undergo genetic
testing, including amniocentesis, to establish whether or not there are any
genetic or chromosomal abnormalities. Yet is this not a strange requirement
for the gestational surrogate? The gestational surrogate is not the genetic carrier
of the problems being screened for. Obviously genetic counseling has no
function for her. Such counseling is relevant to the genetic couple, but it is
the surrogate who is subjecting herself to the testing. Once again she would
have the right not to abort a defective fetus, but if the couple then rejects
the fetus, who gets the child? Unless the surrogate chooses to keep the child
with ne genetic link to her, the child may become a ward of the state. What
if she does choose to abort the fetus, because she does not want to carry a
"defective" pregnancy, and the couple still wants the pregnancy to continue?
It is the couple's genetic material, and they are willing to accept the result.
Yet, if they desire the surrogate to have genetic testing, it would seem that
the couple would have to accept her decision to abort. Regardless of the result,
the use of genetic testing with gestational surrogates raises unique ethical
and legal challenges for the provider.
Control of Behavioral Lifestyle and Work Environment

In addition to genetic testing, surrogate contracts often require that surrogates do not drink, smoke, or take illicit drugs. Obviously enforcement of such
provisions is problematic. Such provisions require that the physician take on
the role of spy rather than fiduciary toward the patient. In fact, the ACOG
committee opinion clearly provides that the confidential relationship remains
with the surrogate. 55
However, with gestational surrogacy it would seem that the couple,
and perhaps the physician, will feel more a hold on the gestational
surrogate. Since she has no genetic connection to the pregnancy, they may fear
she will be less concerned with taking care of herself and the fetus. There have
been cases in which health care providers have gone to court to try to force
certain treatments or cesarean section deliveries. 56 A couple, with the support
of the provider, having invested so much time, emotional energy, and money
in achieving a pregnancy, may feel they have no recourse other than to go
to court to protect their genetic material from the negative behaviors of the
surrogate. The couple might try to argue that their intention to rear the child,
as well as the force of the contract, gives them legal standing to seek an
injunction to get the surrogate to undergo a medical procedure or to stop
smoking, drinking, or taking drugs during the pregnancy. It is not clear whether
the court would be more or less concerned about the autonomy of the pregnant
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woman to control her own body when she has no intention to rear the child
and to accept the consequences of her actions. One also wonders what the
psychological impact of not carrying a genetic fetus has on the acts and
behavior of the surrogate, as well as on the health of the uterine environment. If in fact it is easier to separate, is it easier to ignore other concerns
for the fetus?
Furthermore, what will be the implications for employment of the surrogate? Is gestating her only job? Does she have the right to continue any other
employment? If she works in a lead factory, must she be forced to be transferred or fired? 57 What if she is having twins and is told "to get off her feet?"
If she stops working, will the couple pay her lost earnings? Will she be barred
from disability payments if her pregnancy resulted from an embryo transfer
for hire? What role will the provider play in helping her to obtain disability
,ceverage? With the increase in medical risks come increasing economic risks.
.
'
Birth Defects and Causation

Unfortunately, no one can guarantee the birth of a healthy child. With gestational surrogacy, it may be more difficult to determine the cause of a problem
at birth. Was it a genetic problem? Was it the surrogate's work environment?
Was it the one drink? Was it caused by a sexually transmitted disease that
she caught during relations with her husband? Gestational surrogacy takes
genetics out of the picture, but it may be difficult to pin the problem on a
particular cause. In the end, will the couple and/or the surrogate, if she retains
custody, look to the physician for a financial solution through a liability claim?
With so much that cannot be controlled in the birth process, and with such
high expectations and expenses generated from IVF and embryo transfer, a
liability threat from both the surrogate and commissioning couple should not
be minimized.

CONCLUSION

State courts and legislatures, health-professional organizations, and policymakers throughout the world are struggling to develop laws and guidelines
to address the complex questions raised by the expansion of new reproductive technologies. Clearly, infertility specialists are sincerely devoted to trying
to help couples have their own babies. But health care professionals must resist
the temptation to expand the use of IVF and embryo transfer with gestational
surrogacy. The medical, ethical, and legal risks of using another woman to
serve the interests of the infertile couple cannot be minimized. Gestational
surrogacy is not a cure for infertility, but rather a course to be avoided.
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Another version of this paper was published in Law, Medicine and Health Care 1990
(Winter); 18: 345-52.
Johnson v. Calvert, No. 63-31-90 (Orange Cty. Super. Ct. Calif. October 22, 1990).
Gestational surrogacy is used in combination with in vitro fertilization. The fertilized egg
of the genetic mother with the sperm of the genetic father or a sperm donor in vitro is
transferred into the uterus of the surrogate, who is the birth mother. This differs from
what I will term "genetic surrogacy" in which both the egg and gestation are provided by
the surrogate, as was the case with Mary Beth Whitehead.
Since the first birth in 1986, there have been about 80-100 births by gestational
surrogates in this country. Noncommercial gestational surrogacy is also practiced at Bourn
Hall Clinic, Britain's leading IVF clinic, near Cambridge, England. See the Sunday Times
19 Aug 1989.
/d.
Facts reported in the Las Angeles Times 1990 Oct 23; Sect A: 1 (col 5).
Additional facts about the case provided through personal interviews with the lawyers for
Anna Johnson and the Calverts (October 1990).
Johns'on v. Calvert, supra note 1.
See the National Law Journal 1990 Nov 5: p. 36 (The trial court was affirmed, and further
review is pending in the California Supreme Court).
Since the New Jersey Supreme Court declared the surrogacy contract unenforceable in In
re Baby M, 109 N.J. 396, 537 A.2d 1227 (1988), I have been cautioning health professionals
to seriously consider the unanswered ethical and legal questions raised by surrogacy. See,
e.g., Rothenberg. Surrogacy and the Health Care Professional: Baby M and Beyond. In:
Gostin, ed. Surrogate Motherhood: Politics and Privacy (Ind Univ Press, 1990).
See, e.g., Adams. State legislative report: surrogate parenting contract legislation enacted:
1987, 1988 and 1989 legislative sessions. National Conference of State Legislatures 1990;
15(2) and see also 1990 update. 1990 (Jul).
ld. Arizona (1989 Ariz. Sess. Laws 14); Florida (Fla. Stat. Sec. 63.212(1) (1988) although
allowing for pre-planned adoption arrangements with specific terms; Indiana (Ind. Code Sec.
31-8-2-1- to 31-8-2-3) (1988) sets out rights for the surrogate if an agreement is entered
into; Kentucky (Ky. Rev. Stat. Sec. 199.590 (1988); Louisiana (La. Rev. Stat. Ann. Sec.
9: 2713 (1987); Michigan (Mich. Comp. Laws, Sec. 722.851-722.863 (1988); Nebraska (Ne.
Rev. Stat. 674 (1988); Nevada (Nev. Rev. Stat. 127.303.5 (1987); North Dakota (1989
N.D. Sess. Laws 184); Utah (1989 Utah Laws 140); .:Washington (1989 Wash. Laws 404).
Louisiana and Kentucky just discuss surrogacy by insemination, with no discussion of
gestational services and/or surrogacy by embryo transfer.
1089 Ark. Acts 647.
New Hampshire, HB-1426-FN, Chapter 87 (1990).
The Uniform Status of Children of A~sisted Conception Act, drafted by the .National
Conference of Commissioners on Uniform State Laws (1988), provides for one altt;rnative that declares surrogacy contracts unenforceable (the alternative adopted by North Dakota)
and it establishes that the birth mother is the legal mother. The other alternative, not adopted
by any legislature, does provide that a surrogate who also provides the egg can change
her mind within 180 days after the last insemination, but makes no similar provision for
the gestationl!l surrogate. There is no discussion on why the distinction was made, but
this provision was a major political compromise.
See New York State Task Force on Life and the Law. Surrogate Parenting: Analysis and
Recommendations for Public Policy. New York; New Jersey Task Force on New Reproductive Practices. Policy recommendations on surrogacy. New Jersey, 1990 (Jul).
New Jersey Task Force, supra note 14 at 2.
See generally Stepan (ed.), International Survey of Laws on Assisted Procreation, Zurich,
1990 (hereinafter Survey). The Ontario Law Reform Commission and a recent Australian
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National Bioethics Consultative Committee report do recommend limited approval and strict
regulation of supervised, noncommercial surrogacy contracts.
17. See Survey, supra note 16.
18. Bulgaria Family Code, Art. 31 (May 1985), reprinted in Survey, supra note 16 at 95.
19. Israeli Public Health (In Vitro Fertilization) Regulations, Ministry of Health (1987) at sec.
11, reprinted in Survey, supra note 16 at 121, 124.
20. Norwegian Law on Artificial Fertilization, No. 68, Chapter ill, 1987, reprinted in Survey
at 139, 141; Swedish Law on Fertilization Outside the Human Body, No. 711, at 2, 1988,
reprinted in Survey, supra note 16 at 172.
21. Spanish Law on Assisted Reproduction Procedures, No. 35/1988, Chapter 10, 1988, reprinted
in Survey, supra note 16 at 157, 161.
22. United Kingdom Surrogacy Arrangements Act, 1985, reprinted in Survey, supra note 16
at 184.
23. See Reproductive Rights Reporter 1990 (Oct 26) TI, 19 at 8.
24. Council of Europe, Human Artificial Procreation Strasbourg, 1989, Principle 14 at 28-29.
25. Id. Principle 15 at 29-30.
26. Id.
27. Opinions of the A.M.A. Council on Ethical and Judicial Affairs (Dec. 1988).
28. Ethics Committee of the American Fertility Society, Ethical Considerations of the New
, · ~-.Reproductive Technologies. 'Surrogate gestational mothers' (Chapter 21 at 64S-67S) and
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